Authors
Latest:
Bladder augmentation: What the future holdsThis article reviews current developments in cellular scaffods, the process of cell seeding, and the importance of a favorable in vitro environment for regeneration.
Latest:
Bladder augmentation: What the future holdsThis article reviews current developments in cellular scaffods, the process of cell seeding, and the importance of a favorable in vitro environment for regeneration.
Latest:
Bladder augmentation: What the future holdsThis article reviews current developments in cellular scaffods, the process of cell seeding, and the importance of a favorable in vitro environment for regeneration.
Latest:
Study: No significant link between diabetes Tx, bladder CaA new study reports no statistically significant increase in the risk of bladder cancer among patients treated with the diabetes drug pioglitazone (Actos), despite previous studies suggesting an association.
Latest:
ACA changes create fresh collecting challenges for urology practicesIf you’re in private practice, your profits will be directly affected by how your staff can manage and adapt to ACA-related coverage changes.
Latest:
Challenging case: Hematuria in man with a history of prostate CaA 63-year-old African-American male presents to the emergency department with sudden onset of painless gross hematuria for one day. He reports dark red urine with clots causing occasional dysuria, difficulty emptying, and light-headedness.
Latest:
Laparoendoscopic single-site surgery in urologic patients: What does the future hold?In this article, we briefly review the literature suggesting LESS is safe and holds a potential advantage over conventional laparoscopy. We then describe our techniques and outcomes for performing an extirpative (nephrectomy) and reconstructive (pyeloplasty) LESS procedure.
Latest:
The evolving role of microRNAs in testicular cancer management"This brief review captures the evolving role of miRNAs, focusing on their clinical relevance and implications as well as future directions for more effective targeted therapeutic interventions," write the authors.
Latest:
Large retrospective study identifies racial disparity in surgical management for BPHA logistic regression analysis controlling for other major comorbidities, patient age, insurance status, and type of medical therapy found that Black patients were almost 40% less likely than White patients to undergo surgery for BPH.
Latest:
Is low-intensity surveillance feasible for patients with high-risk NMIBC?The study compared regimens for patients with high-risk non–muscle invasive bladder cancer.
Latest:
AACU: Circumcision controversy could hike urologists' liability premiumsControversies related to circumcision could lead to a rise in medical liability for urologists performing this procedure, writes the American Association of Clinical Urologists' Tim Lytle.
Latest:
How to reward employees for a job well doneHere are some tips for developing an incentive plan that will keep your medical staff motivated.
Latest:
Pre-visit BPH decision aid provides valuable insights and optimizes careThe research also showed that the decision aid was well-received by patients as both satisfaction of men who used the tool and their willingness to recommend their physician were very high.
Latest:
What is your reaction to the new AMA president describing health care as being in crisis?"The burden of preauthorization, reimbursements not keeping up with inflation, and consequently, our abilities to staff and maintain our offices and pay our employees at appropriate levels are also affecting our ability to care for patients," said urologist Ronald P. Kaufman Jr, MD.
Latest:
PSA disadvantages discussed with minority of menA minority of patients are involved in shared decision-making about prostate cancer screening with PSA, but new strategies to incorporate shared decision-making into practice are being investigated.
Latest:
Majority of nocturia patients have nocturnal polyuriaDrs. Shlomo Raz and Ja-Hong Kim discuss recent advances in the treatment of stress incontinence.
Latest:
FDA approves 2 PARP inhibitors for certain men with prostate cancerThe FDA has approved 2 poly (ADP-ribose) polymerase (PARP) inhibitors for men with metastatic castration-resistant prostate cancer who have certain genetic mutations, marking the first approvals of this newer drug class in prostate cancer.
Latest:
UroLift vs. TURP: New gold standard for BPH?In this video, Neil Baum, MD, compares UroLift with other BPH management strategies and also discusses his experience with the use of nitrous oxide as an effective sedative during in-office urologic procedures.
Latest:
How to bill for a locum tenens during a transition periodThere are different ways to go about billing for a locum tenens depending on your circumstances.
Latest:
Opportunistic salpingectomy in female urologic surgeryEvidence suggests fallopian tube removal will lead to reduced ovarian cancer incidence.
Latest:
Cost considerations in the management of bladder cancer"We will review the evidence and identify potential areas of improvement that can help reduce costs associated with UCB management while improving outcomes," write Daniel J. Lee, MD, and Sam S. Chang, MD.
Latest:
Marijuana use prevalent among chronic prostatitis/chronic pelvic pain syndrome patientsWith marijuana legalized for medical use in Canada since 2001 and now in 17 U.S. states and the District of Columbia, urology patients in pain have been turning to marijuana for relief.
Latest:
Report urges action on physician burnoutA new report by the National Academy of Medicine urges action by government, educational institutions, and health care organizations to address the causes of physician burnout, which is experienced by up to one-half of clinicians in the U.S. and threatens patient care.
Latest:
23 years of helping urologists play physicians’ MonopolyI wanted to take this opportunity to say thank you to all who have read my “Coding and Reimbursement” and “Coding Q&A” articles for the past 23 years.
Latest:
CPT 49186 vs 38780: Coding retroperitoneal mass excision"We believe the confusion comes from the typical lexicon surgeons use when performing surgeries, rather than the actual code descriptor and the procedure performed," write Jonathan Rubenstein, MD, and Mark Painter.
Latest:
Prostate cancer study highlights complexity of ‘appropriate’ care"Deciding what care is appropriate is already extraordinarily difficult but will be a growing problem for the next generation of physicians and society," writes Peter C. Albertsen, MD.
Latest:
'Medical home' gaining traction, but at what cost?The controversial concept of medical home calls for a team led by a physician, usually a primary care physician, to be paid extra to handle personalized coordination of a patient's care across the health care system, including acting as liaison with other providers.
Latest:
Renal AML: The role of laparoscopic cryoablationFive-year recurrence and disease-free survival rates for laparoscopic cryoablation are equivalent to those of standard open surgical techniques.
Latest:
Prostate cancer treatments: Assessing effects on quality of lifeThe most instructive HRQoL studies are those that rely on prospective, longitudinal assessments of patients using a validated instrument.
Latest:
Prostate cancer treatments: Assessing effects on quality of lifeThe most instructive HRQoL studies are those that rely on prospective, longitudinal assessments of patients using a validated instrument.
